載入中
NYSEHealthcareMedical - Devices
最新資料
US$91.54
+US$2.40 · +2.69%
Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The firm also offers sports medicine, biologics, extremities, and trauma products, spine, craniomaxillofacial, and thoracic products, office-based technologies, dental implants, and related surgical products. It operates through the following geographical segments: Americas, Europe Middle East and Africa, and Asia Pacific. The Americas segment consists of the U.S. and includes other North, Central and South American markets. The Europe Middle East and Africa segment includes France, Germany, Italy, Spain, and the United Kingdom. The Asia Pacific segment refers to the key markets such as Japan, China, Australia, New Zealand, Korea, Taiwan, India, Thailand, Singapore, Hong Kong, and Malaysia. The company was founded by Justin O. Zimmer in 1927 and is headquartered in Warsaw, IN.
一般交易時段
US$91.54
+US$2.40 · +2.69%
盤中時間採用ET。市場資料可能有所延遲。
Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The firm also offers sports medicine, biologics, extremities, and trauma products, spine, craniomaxillofacial, and thoracic products, office-based technologies, dental implants, and related surgical products. It operates through the following geographical segments: Americas, Europe Middle East and Africa, and Asia Pacific. The Americas segment consists of the U.S. and includes other North, Central and South American markets. The Europe Middle East and Africa segment includes France, Germany, Italy, Spain, and the United Kingdom. The Asia Pacific segment refers to the key markets such as Japan, China, Australia, New Zealand, Korea, Taiwan, India, Thailand, Singapore, Hong Kong, and Malaysia. The company was founded by Justin O. Zimmer in 1927 and is headquartered in Warsaw, IN.
日內區間
目前US$91.54
52週區間
目前US$91.54
盤中時間採用ET。市場資料可能有所延遲。
Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The firm also offers sports medicine, biologics, extremities, and trauma products, spine, craniomaxillofacial, and thoracic products, office-based technologies, dental implants, and related surgical products. It operates through the following geographical segments: Americas, Europe Middle East and Africa, and Asia Pacific. The Americas segment consists of the U.S. and includes other North, Central and South American markets. The Europe Middle East and Africa segment includes France, Germany, Italy, Spain, and the United Kingdom. The Asia Pacific segment refers to the key markets such as Japan, China, Australia, New Zealand, Korea, Taiwan, India, Thailand, Singapore, Hong Kong, and Malaysia. The company was founded by Justin O. Zimmer in 1927 and is headquartered in Warsaw, IN.
日內區間
目前US$91.54
52週區間
目前US$91.54
獲利能力占已公布營收的百分比。
營收
營業利益
淨利
| 項目（USD） | 2025會計年度 | 2024會計年度 | 2023會計年度 | 2022會計年度 | 2021會計年度 |
|---|---|---|---|---|---|
| 營收 | 82.32億 USD | 76.79億 USD | 73.94億 USD | 69.4億 USD | 68.27億 USD |
| 銷貨成本 | 31.6億 USD | 21.91億 USD | 20.84億 USD | 20.2億 USD | 19.6億 USD |
| 毛利 | 50.72億 USD | 54.87億 USD | 53.1億 USD | 49.2億 USD | 48.67億 USD |
| 研究與開發 | 4.59億 USD | 4.37億 USD | 4.59億 USD | 4.06億 USD | 4.36億 USD |
| 銷售、一般及管理費用 | 32.51億 USD | 29.3億 USD | 28.39億 USD | 27.62億 USD | 28.43億 USD |
| 營業費用 | 37.1億 USD | 42.02億 USD | 40.33億 USD | 42.24億 USD | 40.07億 USD |
| 利息支出 | 2.93億 USD | 2.18億 USD | 2.01億 USD | 1.65億 USD | 2.08億 USD |
| 折舊和攤銷 | 10.94億 USD | 9.96億 USD | 9.52億 USD | 9.26億 USD | 9.38億 USD |
| 營業利益 | 13.62億 USD | 12.86億 USD | 12.78億 USD | 6.96億 USD | 8.6億 USD |
| 淨利 | 7.05億 USD | 9.04億 USD | 10.24億 USD | 2.31億 USD | 4.02億 USD |
公司資料更新於 2026年10月12日。
近期已公布業績
近期已公布業績
第三方分析師預期可能變動，並非 GoAI 建議。
平均目標
US$103.11
上漲空間 12.64%AI 生成內容及延遲市場資料僅供資訊與教育用途，不構成投資建議。
